Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker NRIX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Hans van Houte Chief Financial Officer | NRIX Nurix Therapeutics, Inc. | Sale | 1,469 | $16.20 | $23.8K Sale | Form 4 ↗ |
| Nov 4, 2026 | Hans van Houte Chief Financial Officer | NRIX Nurix Therapeutics, Inc. | Sale | 3,300 | $15.38 | $50.8K Sale | Form 4 ↗ |
| Nov 3, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 6,113 | $25.83 | $157.9K Sale | Form 4 ↗ |
| Nov 2, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 1,075 | $26.76 | $28.8K Sale | Form 4 ↗ |
| Nov 2, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 9,527 | $25.74 | $245.2K Sale | Form 4 ↗ |
| Nov 2, 2026 | Gwenn Hansen Chief Scientific Officer | NRIX Nurix Therapeutics, Inc. | Sale | 1,452 | $26.80 | $38.9K Sale | Form 4 ↗ |
| Oct 30, 2026 | Hans van Houte Chief Financial Officer | NRIX Nurix Therapeutics, Inc. | Sale | 2,834 | $26.28 | $74.5K Sale | Form 4 ↗ |
| Oct 30, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 3,957 | $26.28 | $104.0K Sale | Form 4 ↗ |
| Oct 30, 2026 | Gwenn Hansen Chief Scientific Officer | NRIX Nurix Therapeutics, Inc. | Sale | 3,957 | $26.28 | $104.0K Sale | Form 4 ↗ |
| Sep 2, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 400 | $26.64 | $10.7K Sale | Form 4 ↗ |
| Sep 2, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 5,387 | $25.69 | $138.4K Sale | Form 4 ↗ |
| Sep 1, 2026 | Gwenn Hansen Chief Scientific Officer | NRIX Nurix Therapeutics, Inc. | Sale | 1,452 | $25.47 | $37.0K Sale | Form 4 ↗ |
| Aug 5, 2026 | Gwenn Hansen Chief Scientific Officer | NRIX Nurix Therapeutics, Inc. | Sale | 4,356 | $25.00 | $108.9K Sale | Form 4 ↗ |
| Aug 4, 2026 | Hans van Houte Chief Financial Officer | NRIX Nurix Therapeutics, Inc. | Sale | 2,967 | $24.65 | $73.1K Sale | Form 4 ↗ |
| Aug 4, 2026 | Hans van Houte Chief Financial Officer | NRIX Nurix Therapeutics, Inc. | Sale | 1,794 | $23.89 | $42.9K Sale | Form 4 ↗ |
| Aug 4, 2026 | Gwenn Hansen Chief Scientific Officer | NRIX Nurix Therapeutics, Inc. | Sale | 2,611 | $24.64 | $64.3K Sale | Form 4 ↗ |
| Aug 4, 2026 | Gwenn Hansen Chief Scientific Officer | NRIX Nurix Therapeutics, Inc. | Sale | 1,500 | $23.87 | $35.8K Sale | Form 4 ↗ |
| Aug 3, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 16,589 | $23.05 | $382.4K Sale | Form 4 ↗ |
| Jul 30, 2026 | Hans van Houte Chief Financial Officer | NRIX Nurix Therapeutics, Inc. | Sale | 2,845 | $23.38 | $66.5K Sale | Form 4 ↗ |
| Jul 30, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 3,847 | $23.38 | $89.9K Sale | Form 4 ↗ |
| Jul 30, 2026 | Gwenn Hansen Chief Scientific Officer | NRIX Nurix Therapeutics, Inc. | Sale | 3,847 | $23.38 | $89.9K Sale | Form 4 ↗ |
| Jul 2, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 11,008 | $23.56 | $259.3K Sale | Form 4 ↗ |
| Jun 25, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 28,935 | $20.06 | $580.4K Sale | Form 4 ↗ |
| Jun 25, 2026 | Gwenn Hansen Chief Scientific Officer | NRIX Nurix Therapeutics, Inc. | Sale | 5,394 | $20.00 | $107.9K Sale | Form 4 ↗ |
| Jun 2, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 8,148 | $16.60 | $135.3K Sale | Form 4 ↗ |
| May 5, 2026 | Hans van Houte Chief Financial Officer | NRIX Nurix Therapeutics, Inc. | Sale | 582 | $17.18 | $9,999 Sale | Form 4 ↗ |
| May 5, 2026 | Hans van Houte Chief Financial Officer | NRIX Nurix Therapeutics, Inc. | Sale | 13,473 | $16.58 | $223.4K Sale | Form 4 ↗ |
| May 4, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 8,148 | $16.96 | $138.2K Sale | Form 4 ↗ |
| May 1, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 5,394 | $16.76 | $90.4K Sale | Form 4 ↗ |
| Apr 30, 2026 | Hans van Houte Chief Financial Officer | NRIX Nurix Therapeutics, Inc. | Sale | 2,388 | $16.65 | $39.8K Sale | Form 4 ↗ |
| Apr 30, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 3,214 | $16.65 | $53.5K Sale | Form 4 ↗ |
| Apr 30, 2026 | Gwenn Hansen Chief Scientific Officer | NRIX Nurix Therapeutics, Inc. | Sale | 3,214 | $16.65 | $53.5K Sale | Form 4 ↗ |
| Apr 2, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 8,148 | $15.24 | $124.2K Sale | Form 4 ↗ |
| Mar 2, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 8,148 | $15.44 | $125.8K Sale | Form 4 ↗ |
| Feb 9, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 14,261 | $16.66 | $237.6K Sale | Form 4 ↗ |
| Jan 30, 2026 | Hans van Houte Chief Financial Officer | NRIX Nurix Therapeutics, Inc. | Sale | 73 | $17.37 | $1,268 Sale | Form 4 ↗ |
| Jan 30, 2026 | Hans van Houte Chief Financial Officer | NRIX Nurix Therapeutics, Inc. | Sale | 3,588 | $16.58 | $59.5K Sale | Form 4 ↗ |
| Jan 30, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 88 | $17.37 | $1,529 Sale | Form 4 ↗ |
| Jan 30, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 4,333 | $16.58 | $71.8K Sale | Form 4 ↗ |
| Jan 30, 2026 | Gwenn Hansen Chief Scientific Officer | NRIX Nurix Therapeutics, Inc. | Sale | 98 | $17.37 | $1,702 Sale | Form 4 ↗ |
| Jan 30, 2026 | Gwenn Hansen Chief Scientific Officer | NRIX Nurix Therapeutics, Inc. | Sale | 4,797 | $16.58 | $79.5K Sale | Form 4 ↗ |
| Jan 20, 2026 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 3,760 | $18.42 | $69.3K Sale | Form 4 ↗ |
| Dec 18, 2025 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 200 | $18.56 | $3,712 Sale | Form 4 ↗ |
| Dec 18, 2025 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 3,560 | $17.87 | $63.6K Sale | Form 4 ↗ |
| Nov 24, 2025 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 37,600 | $17.07 | $641.8K Sale | Form 4 ↗ |
| Nov 3, 2025 | Hans van Houte Chief Financial Officer | NRIX Nurix Therapeutics, Inc. | Sale | 6,284 | $12.56 | $78.9K Sale | Form 4 ↗ |
| Oct 30, 2025 | Hans van Houte Chief Financial Officer | NRIX Nurix Therapeutics, Inc. | Sale | 3,130 | $12.80 | $40.1K Sale | Form 4 ↗ |
| Oct 30, 2025 | Christine Ring Chief Legal Officer | NRIX Nurix Therapeutics, Inc. | Sale | 3,644 | $12.80 | $46.6K Sale | Form 4 ↗ |
| Oct 30, 2025 | Gwenn Hansen Chief Scientific Officer | NRIX Nurix Therapeutics, Inc. | Sale | 4,087 | $12.80 | $52.3K Sale | Form 4 ↗ |
| Aug 1, 2025 | Hans van Houte Chief Financial Officer | NRIX Nurix Therapeutics, Inc. | Sale | 5,402 | $11.03 | $59.6K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:03 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances